SCHEMBL6921173

SCHEMBL6921173

Oc1cccc2c1c1ccccc1n2Cc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.65
P2RX4 Q99571 1/20 0.57
MEN1 O00255 5/20 0.56
KMT2A Q03164 5/20 0.56
ALDH1A1 P00352 4/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
MAPT P10636 2/20 0.56
KDM4E B2RXH2 1/20 0.56
SRC P12931 1/20 0.56
PLA2G2A P14555 1/20 0.52
MAPK1 P28482 2/20 0.51
POLB P06746 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
PGR P06401 1/20 0.48
UTS2R Q9UKP6 1/20 0.46
PRKDC P78527 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7723992 0.86 SRC (0.53) CYP19A1P2RX4MEN1KMT2AALDH1A1
SCHEMBL28735017 0.86 CYP19A1 (0.56) CYP19A1P2RX4MEN1KMT2AALDH1A1
SCHEMBL29588112 0.86 CYP19A1 (0.56) CYP19A1P2RX4MEN1KMT2AALDH1A1
SCHEMBL6924327 0.85 SRC (0.51) CYP19A1P2RX4MEN1KMT2AALDH1A1
SCHEMBL6923669 0.84 SRC (0.50) CYP19A1P2RX4MEN1KMT2AALDH1A1
SCHEMBL6923659 0.84 KMT2A (0.51) CYP19A1P2RX4MEN1KMT2AALDH1A1
SCHEMBL6926546 0.83 CYP19A1 (0.47) CYP19A1P2RX4MEN1KMT2AALDH1A1
SCHEMBL6927392 0.82 ATM (0.53) CYP19A1P2RX4MEN1KMT2AALDH1A1
SCHEMBL6924122 0.82 PLA2G2A (0.46) CYP19A1P2RX4MEN1KMT2AALDH1A1
SCHEMBL6920467 0.81 PLA2G2A (0.55) P2RX4KMT2APLA2G2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1169789-C Aminoalkoxy carbazoles for the treatment of CNS diseases 法玛西雅厄普约翰美国公司 2004-10-06 CN disclosed
US-6514968-B1 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising PHARMACIA & UPJOHN COMPANY 2003-02-04 US disclosed
CN-1372547-A Aminoalkoxy carbazoles for the treatment of CNS diseases UPJOHN CO (US) 2002-10-02 CN disclosed
EP-1210329-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-06-05 EP disclosed
WO-2001017963-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2001-03-15 WO disclosed